Biotechnology, Pharma and Healthcare Market Research +91 70133 15430 info@ameyamrs.com

8 reports

AM-RS-004

Artificial Intelligence in Drug Discovery

AI drug discovery is studied across target identification, molecule design, virtual screening, ADMET prediction and clinical trial design. The report covers software platforms, discovery…

November 2026 edition From US$3,200
AM-RS-001

Compound Screening Libraries

Compound screening libraries are studied by library type, including diversity, focused, fragment, natural product and DNA-encoded collections. The report covers purchase and access models…

November 2026 edition From US$3,000
AM-RS-002

Humanized Animal Models

Humanized animal models are assessed by model type, covering humanized immune system, liver and gene-humanized mice and rats. Oncology, immunology, infectious disease and drug metabolism…

November 2026 edition From US$3,000
AM-RS-006

Molecular Glues

Molecular glues are examined as a degrader modality that redirects E3 ligases to new protein targets. The report reviews discovery approaches, approved and pipeline compounds, screening…

November 2026 edition From US$3,400
AM-RS-003

Organ-on-Chip

Organ-on-chip is examined as a technology platform spanning liver, lung, kidney, gut, heart and multi-organ systems. The study covers chips, instruments and services, uses in toxicology and…

November 2026 edition From US$3,200
AM-RS-007

Organoids

Organoids are studied by tissue type, including intestinal, liver, kidney, lung, tumor and brain models, and by use in disease modeling, drug screening and personalized medicine. Culture…

November 2026 edition From US$2,800
AM-RS-005

Proteolysis-Targeting Chimeras

PROTACs and related targeted protein degraders are reviewed from E3 ligase biology to clinical development. The study covers pipeline programs by therapeutic area, chemistry and linker…

November 2026 edition From US$3,400
AM-RS-008

Undruggable Target Discovery

Undruggable target discovery is reviewed across the approaches that reach transcription factors, scaffolding proteins and other difficult targets. Covalent chemistry, protein degradation…

November 2026 edition From US$2,800

Leave a Message

Unsubscribe